Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Roche, Biotech to Discover New Antibiotics

A biotechnology company that discovers new drugs through detailed genomic analysis is partnering with drug maker Roche to find new treatments for bacterial infections that resist current antibiotics. . . . → Read More: Roche, Biotech to Discover New Antibiotics

Biotech Licenses Gene Editing for Autoimmune Disorders

A company developing therapies with gene editing technologies is acquiring a new form of gene editing on T-cells in the immune system to treat autoimmune diseases. . . . → Read More: Biotech Licenses Gene Editing for Autoimmune Disorders

Patent Awarded for Live Bacterial Acne Treatment

A company developing treatments for disease by restoring the natural balance of bacteria on the skin received a patent for its acne therapy using spray-on live bacteria. . . . → Read More: Patent Awarded for Live Bacterial Acne Treatment

Drug Delivery Technology Licensed in $2B Deals

The biotechnology company Halozyme Therapeutics Inc. is licensing its technology for making infusion drugs deliverable with injections to two more drug makers. . . . → Read More: Drug Delivery Technology Licensed in $2B Deals

AstraZeneca, Biotech Partner on Messenger RNA Therapies

Global drug maker AstraZeneca is acquiring an option to license the rights to a technology based on genetic material transcribed from DNA, for new respiratory disease treatments. . . . → Read More: AstraZeneca, Biotech Partner on Messenger RNA Therapies

Patent Set for Peptide Nerve Damage Treatments

The European Patent Office announced its intent to award a patent on treatments for nerve cell damage based on the peptide thymosin beta 4. . . . → Read More: Patent Set for Peptide Nerve Damage Treatments

Life Science Execs: Financial, IP Info Top Hacker Targets

Technology executives at pharmaceutical and medical device enterprises in the U.S. say financial and intellectual property assets are their top targets for hackers, according to survey results released today. . . . → Read More: Life Science Execs: Financial, IP Info Top Hacker Targets

Lilly Licensing Autoimmune Therapy in $400M Deal

Drug maker Eli Lilly and Company is licensing a therapy from a biotechnology company that produces self-correcting cells for people with disorders caused by a malfunctioning immune system. . . . → Read More: Lilly Licensing Autoimmune Therapy in $400M Deal

Patent Awarded for Exosome Capture Process

A company making blood filtering devices was awarded a patent for a process to capture tiny particles carrying proteins that suppress immune responses. . . . → Read More: Patent Awarded for Exosome Capture Process

Biotech Licensing Viral T-Cell Immunotherapies

A company making treatments for viral infections that stimulate natural T-cells in the immune system is licensing a related technology from Baylor College of Medicine. . . . → Read More: Biotech Licensing Viral T-Cell Immunotherapies